63 related articles for article (PubMed ID: 1818401)
1. Immune response in acute Toxoplasma infection of Balb/C, ICR and CBA/J mice.
Suresh K; Mak JW; Yong HS
Southeast Asian J Trop Med Public Health; 1991 Sep; 22(3):452-4. PubMed ID: 1818401
[No Abstract] [Full Text] [Related]
2. Toxoplasma gondii: cold stress-induced modulation of antibody responses.
Aviles HO; Monroy FP
Exp Parasitol; 2001 Oct; 99(2):89-96. PubMed ID: 11748962
[TBL] [Abstract][Full Text] [Related]
3. Toxoplasma gondii: an evaluation of diagnostic value of recombinant antigens in a murine model.
Gatkowska J; Hiszczynska-Sawicka E; Kur J; Holec L; Dlugonska H
Exp Parasitol; 2006 Nov; 114(3):220-7. PubMed ID: 16707125
[TBL] [Abstract][Full Text] [Related]
4. [Serological parameters for the diagnosis and follow-up of toxoplasmosis. Experimental models].
Acebes MV; Díez B; Nicolás R; Martín MT; Suñén E; Cisterna R
Enferm Infecc Microbiol Clin; 1994 Mar; 12(3):141-5. PubMed ID: 8011720
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of immune responses raised against Tc13 antigens of Trypanosoma cruzi in the outcome of murine experimental infection.
García GA; Arnaiz MR; Esteva MI; Laucella SA; Garavaglia PA; Ibarra SE; Ruiz AM
Parasitology; 2008 Mar; 135(3):347-57. PubMed ID: 17991305
[TBL] [Abstract][Full Text] [Related]
6. Optimisation of cut-off titres in Toxoplasma gondii specific ELISA and IFAT in dog sera using immunoreactivity to SAG-1 antigen as a molecular marker of infection.
Silva NM; Lourenço EV; Silva DA; Mineo JR
Vet J; 2002 Jan; 163(1):94-8. PubMed ID: 11749142
[No Abstract] [Full Text] [Related]
7. Toxoplasma gondii: serological characterization and immunogenicity of recombinant surface antigen 2 (SAG2) expressed in the yeast Pichia pastoris.
Lau YL; Fong MY
Exp Parasitol; 2008 Jul; 119(3):373-8. PubMed ID: 18457835
[TBL] [Abstract][Full Text] [Related]
8. Detection of Toxoplasma gondii-specific IgA in the serum of cats.
Burney DP; Lappin MR; Cooper C; Spilker MM
Am J Vet Res; 1995 Jun; 56(6):769-73. PubMed ID: 7653886
[TBL] [Abstract][Full Text] [Related]
9. Toxoplasma gondii: Serological recognition of reinfection.
Dzitko K; Staczek P; Gatkowska J; Dlugonska H
Exp Parasitol; 2006 Feb; 112(2):134-7. PubMed ID: 16289467
[TBL] [Abstract][Full Text] [Related]
10. Feline serum antibody responses to Toxoplasma gondii and characterization of target antigens.
Lappin MR; Bush DJ; Reduker DW
J Parasitol; 1994 Feb; 80(1):73-80. PubMed ID: 8308661
[TBL] [Abstract][Full Text] [Related]
11. [Study on immuno-effect with GRA4 or SAG2 gene recombinant BCG vaccine of Toxoplasma gondii].
Li JH; Wu ST; Weng YB; Gan Y; Liu HB; Liu ML; Zhang RL; Gao ST; Huang DN; Geng YJ
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2007 Jun; 25(3):217-21. PubMed ID: 18038782
[TBL] [Abstract][Full Text] [Related]
12. Antibodies to Toxoplasma gondii major surface protein (SAG-1, P30) inhibit infection of host cells and are produced in murine intestine after peroral infection.
Mineo JR; McLeod R; Mack D; Smith J; Khan IA; Ely KH; Kasper LH
J Immunol; 1993 May; 150(9):3951-64. PubMed ID: 7682587
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of Toxoplasma gondii placental transmission in BALB/c mice model.
Pezerico SB; Langoni H; Da Silva AV; Da Silva RC
Exp Parasitol; 2009 Oct; 123(2):168-72. PubMed ID: 19563804
[TBL] [Abstract][Full Text] [Related]
14. Detection of circulating antigens in the diagnosis of acute toxoplasmosis.
Acebes MV; Diez B; Garcia-Rodriguez JA; Viens P; Cisterna R
Am J Trop Med Hyg; 1994 Oct; 51(4):506-11. PubMed ID: 7943580
[TBL] [Abstract][Full Text] [Related]
15. Murine immune responses to recombinant Toxoplasma gondii antigens.
Parker SJ; Smith FM; Johnson AM
J Parasitol; 1991 Jun; 77(3):402-9. PubMed ID: 2040952
[TBL] [Abstract][Full Text] [Related]
16. Diagnosis of recent Toxoplasma gondii infection in cats by use of an enzyme-linked immunosorbent assay for immunoglobulin M.
Lappin MR; Greene CE; Prestwood AK; Dawe DL; Tarleton RL
Am J Vet Res; 1989 Sep; 50(9):1580-5. PubMed ID: 2802336
[TBL] [Abstract][Full Text] [Related]
17. Toxoplasma gondii: protective effect of an intranasal SAG1 and MIC4 DNA vaccine in mice.
Wang H; He S; Yao Y; Cong H; Zhao H; Li T; Zhu XQ
Exp Parasitol; 2009 Jul; 122(3):226-32. PubMed ID: 19366622
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of immunization with tachyzoite excreted-secreted proteins in a novel susceptible mouse model (A/Sn) for Toxoplasma gondii.
Costa-Silva TA; Meira CS; Ferreira IM; Hiramoto RM; Pereira-Chioccola VL
Exp Parasitol; 2008 Nov; 120(3):227-34. PubMed ID: 18706414
[TBL] [Abstract][Full Text] [Related]
19. Mucosal and systemic suppression of the immune response to E. histolytica provoked by metronidazole and mebendazole in Balb/c mice.
Moreno-Fierros L; Nuñez E; López-Revilla R; Verdín L
Proc West Pharmacol Soc; 1998; 41():99-102. PubMed ID: 9836259
[No Abstract] [Full Text] [Related]
20. Toxoplasma gondii: expression pattern and detection of infection using full-length recombinant P35 antigen.
Lu B; Wu S; Shi Y; Zhang R; Zou L; Gao S; Lin M; Zhou Y
Exp Parasitol; 2006 Jun; 113(2):83-90. PubMed ID: 16458298
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
